Tumefactive Lesions as Debut of Multiple Sclerosis (P11-20.007)

Ana Paula Sieben Samek; M. Cecilia Pita; Ricardo Alonso

doi:10.1212/wnl.0000000000216397

June 9, 2026Neurology

Tumefactive Lesions as Debut of Multiple Sclerosis (P11-20.007)

View at Publisher

Ask AI

Bookmark

Share

Key Points

This study aims to detail the demographics, clinical features, and imaging characteristics of patients with initial multiple sclerosis symptoms linked to tumefactive lesions.
Cohort from Latin America with patients experiencing first MS symptoms
Assessment of demographic data, clinical features, and radiological findings
Analysis of tumefactive demyelinating lesions as a manifestation of MS
Identification of specific demographic trends among patients with TDLs
Observation of distinct clinical presentations related to TDLs
Radiological findings highlighting the characteristics of TDLs in MS

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

The aim of this study is to describe the demographic, clinical, and radiological characteristics of patients whose first MS manifestation was associated with tumefactive demyelinating lesions (TDLs) in a Latin American cohort.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Samek et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf3b4faef96ed7f056293 https://doi.org/10.1212/wnl.0000000000216397

View at Publisher

Ask AI

Bookmark

Share

Tumefactive Lesions as Debut of Multiple Sclerosis (P11-20.007)

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Tumefactive Lesions as Debut of Multiple Sclerosis (P11-20.007)

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading